Merz Aesthetics

Merz Announces New VP and Head of Global Medical Affairs

Merz Introduces new head of global medical affairs

Terri L. Phillips, MD, FAAP, is the new vice president and head of global medical affairs at Merz. She will oversee the global medical affairs team and work out of the Merz North America headquarters in Raleigh, North Carolina. Prior to joining Merz, Dr. Phillips served as vice president of global medical affairs at Santen, chief scientific officer and principal at Scientific Commercialization, head of medical affairs at NPS Pharmaceuticals and also spent nine years at Allergan.

DESCRIBE PFD Patch Cleared for Use With Additional Wavelengths

Perfluorodecalin-infused patch cleared for use with additional wavelengths

The U.S. Food and Drug Administration (FDA) has cleared the DESCRIBE PFD Patch (Merz Aesthetics), a single-use, perfluorodecalin-infused clear patch used during laser treatment of tattoos, for all commonly used wavelengths for tattoo removal. The Patch, which is placed over tattoos prior to treatment, allows practitioners to perform rapid multiple laser passes in a single treatment session. It was previously cleared in April 2015 for use with the 755nm QS Alexandrite laser, which is effective in removal of tattoos with blue or black ink.

Merz Acquires ON Light Sciences

Merz North America has acquired ON Light Sciences, maker of the DeScribe Transparent PFD (perfluorodecalin) patch for laser tattoo removal. The DeScribe patch is placed over tattoos prior to irradiation, allowing physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session. It also provides optical clearing of tissue, protects the epidermis and inhibits potentially infectious back-splatter and fumes.

Cellulite Solution

Rollout of the FDA-approved Cellfina System provides a minimally invasive, long-lasting cellulite treatment option with high patient satisfaction levels.
Cellulite Solution

“We finally have a solution for many patients who come in complaining about cellulite,” says Daniel C. Mills, MD, director of the Aesthetic Plastic Surgical Institute in Laguna Beach, California, and one of four physicians chosen by Ulthera to work on clinical applications for its latest device, Cellfina.

Mederma Named No. 1 for Scars and Stretch Marks

Pharmacy Times and U.S. News & World Report have named Mederma (Merz Aesthetics) the No.1 pharmacist-recommended brand for treating scars and stretch marks.

Mederma offers a range of over-the-counter products to treat the appearance of scars caused by cuts, scrapes, burns, acne and surgery, including PM Intensive Overnight Scar Cream, Advanced Scar Gel, Scar Cream Plus SPF 30 and Mederma For Kids, while Mederma Stretch Marks Therapy combines ingredients like proprietary botanical extract Cepalin and hyaluronic acid.

Merz Appoints Two New VPs

Merz North America named David Dobrowski the vice president and head of North American Research and Development, effective immediately. He will be responsible for all medical, regulatory and product safety functions for Merz in North America and will lead the planning and execution of all clinical and pre-clinical development programs. He will additionally serve as the global lead on all Merz R&D activities relating to medical dermatology.

Radiesse Approved for Hand Augmentation

Radiesse Approved for Hand Augmentation

Radiesse (Calcium Hydroxylapatite, Merz Aesthetics) has received U.S. Food and Drug Administration approval for hand augmentation to correct volume loss in the dorsum of the hands. The long-term filler provides an immediate volumizing effect and can help to reduce the prominence of tendons and veins in the hands, delivering smooth, natural-looking results that can last up to one year.